Evidence map›Paper›PMID 39841829›Full record

ArticleScience advances2025

Mitochondrial respiratory complex III sustains IL-10 production in activated macrophages and promotes tumor-mediated immune evasion.

Alessia Zotta, Juliana Toller-Kawahisa, Eva M Palsson-McDermott, Shane M O'Carroll, Órlaith C Henry, Emily A Day, Anne F McGettrick, Ross W Ward, Dylan G Ryan, Mark A Watson and 8 more

Abstract read
In one paragraph

Article in Science advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. A novel prognostic and immune-related biomarkerTranslational cancer research · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Alessia ZottaSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.ORCID 0009-0004-0158-3241
Juliana Toller-KawahisaSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.ORCID 0000-0001-7323-5036
Eva M Palsson-McDermottSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.
Shane M O'CarrollSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.ORCID 0000-0002-3485-6128
Órlaith C HenrySchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.ORCID 0009-0008-7233-2852
Emily A DaySchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.ORCID 0000-0003-3245-5715
Anne F McGettrickSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.ORCID 0000-0001-6887-7229
Ross W WardSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.ORCID 0000-0001-5242-4022
Dylan G RyanMitochondria Biology Unit, University of Cambridge, Cambridge, UK.
Mark A WatsonBuck Institute for Research on Aging, Novato, CA, USA.ORCID 0000-0002-5423-4457
Martin D BrandBuck Institute for Research on Aging, Novato, CA, USA.ORCID 0000-0003-4418-6153
Marah C RuntschDivision of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.ORCID 0000-0002-9059-9269
Kathrin MaitzDivision of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.ORCID 0009-0006-8180-3906
Anna LuegerDivision of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.ORCID 0009-0007-9644-4763
Julia KarglDivision of Pharmacology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria.ORCID 0000-0002-0870-0816
Jan L MiljkovicMitochondria Biology Unit, University of Cambridge, Cambridge, UK.ORCID 0000-0002-1910-9677
Ed C LavelleSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.ORCID 0000-0002-3167-1080
Luke A J O'NeillSchool of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin 2, Ireland.ORCID 0000-0002-4333-2748

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cytokine interleukin-10 (IL-10) limits the immune response and promotes resolution of acute inflammation. Because of its immunosuppressive effects, IL-10 up-regulation is a common feature of tumor progression and metastasis. Recently, IL-10 regulation has been shown to depend on mitochondria and redox-sensitive signals. We have found that Suppressor of site III

Indexed as

Electron Transport Complex IIIInterleukin-10Macrophage ActivationMacrophagesMitochondriaTumor EscapeAnimalsCell Line, TumorLipopolysaccharidesMelanoma, ExperimentalMiceMice, Inbred C57BLReactive Oxygen SpeciesElectron Transport Complex IIIIL10 protein, mouseInterleukin-10LipopolysaccharidesReactive Oxygen Species

Identifiers

PMID39841829
PMCPMC11789823

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.